Development Of Phagogram News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Development of phagogram. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Development Of Phagogram Today - Breaking & Trending Today

Pherecydes Pharma Announces Its 2020 Annual Financial Results and Confirms Its 2021 Outlook


Pherecydes Pharma Announces Its 2020 Annual Financial Results and Confirms Its 2021 Outlook
Regulatory News:
Pherecydes Pharma (FR0011651694 - ALPHE) (Paris:ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today
announces its annual results for the year to December 31, 2020 and confirms its development prospects for 2021.
Guy-Charles Fanneau de La Horie, Chairman of the Executive Board of Pherecydes Pharma, states: “
Thanks to the resounding success of our Initial Public Offering, we are accelerating the
strategic investments in our R&D and clinical programs. This ramping up is being accompanied by an ongoing very active intellectual property policy that has recently led to the granting of two ....

United States , France General , Hong Kong , Pherecydes Pharma , European Commission , Early Access Program , Research Development , Development Of Phagogram , Bordeaux University Hospital , Programme Hospitalier De Recherche Clinique , Management Committee , Trademark Office , University Hospital , Drug Delivery Congress , European Union , Euronext Growth , United States Patent , Agence Nationale , French National Agency , Annual Inhalation , Respiratory Drug Delivery Congress , Industrial Operations , ஒன்றுபட்டது மாநிலங்களில் , பிரான்ஸ் ஜநரல் , ஹாங் காங் , ஐரோப்பிய தரகு ,